Oren Gilad, President/CEO at Aprea Therapeutics, Inc. (APRE), bought 5,500 shares at $1.80 ($10K) on 2025-04-03, disclosed to the SEC on 2025-04-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.80 | 2,497 | $4K | 44.5% |
| 2 | $1.87 | 3,003 | $6K | 55.5% |
| Total | $1.84 avg | 5,500 | $10K | 100% |
| Filing → |
| APRE | BUY | 2024-10-16 | $725 | — | Filing → |
| APRE | BUY | 2024-10-15 | $3K | — | Filing → |
| APRE | BUY | 2024-03-14 | $15K | — | Filing → |